FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Cytomegalovirus Infection Worsens MS, Study in Mice Shows



















A cytomegalovirus infection triggers an increase in inflammatory and cytotoxic immune cells in mice with MS, which leads to enhanced inflammation and loss of nerve-protecting myelin.


The study, “Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation,” was published in the journal Scientific Reports.

A cytomegalovirus (CMV) infection leads to chronic activation of the immune system. One result is an increase in the number of immune cells called CD4+CD28null T-cells. High levels of this T-cell subgroup are associated with chronic inflammatory diseases.

Some previous studies have suggested a link between CMV infection and MS. But other studies have suggested that CMV-specific antibodies are associated with a better disease outcome, an increased age of disease onset, and decreased brain atrophy.

Researchers decided to see whether CMV is able to trigger an increase in CD4+CD28null T-cells, and how the infection impacts MS disease progression. The team used both mouse models and in vitro, or laboratory, work with human blood samples.

They observed that blood with a CMV infection had higher levels of CD4+CD28null T-cells than blood with no infection. The researchers also found that CMV peptides, or amino acids, increased the number of these cells in a lab.

CD4+CD28null T-cells are inflammatory, toxic cells found in MS lesions. Researchers discovered an increase in the cells in a mouse model of MS, and noted a correlation between the higher number and the severity of the disease. The used the established experimental autoimmune encephalomyelitis (EAE) mouse model of human MS.

Since CD4+CD28null T-cells accumulate in brain lesions in MS patients, researchers wondered whether CMV could contribute to demyelination in the spinal cord of mice with MS. Demyelination is the term used to describe the loss of myelin, a protective coating around nerve-cell projections known as axons in the central nervous system. Myelin damage is a hallmark of MS.

The team observed that CMV-infected EAE mice had more demyelination than a control group of mice.



Story Source: The above story is based on materials provided by
MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length 
Click here to read more


Go to Newer News Go to Older News